Effect of valproic acid on the outcome of glioblastoma multiforme

A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy

(2014) Sunil Sharma et al.   Translational Oncology

Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma: Figure 1

(2010) Shannon A. Kavanaugh et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

HDAC inhibitors and ionizing radiation: Combinatorial strategy to combat lung cancer

(2010) Devanand Sarkar   CANCER BIOLOGY & THERAPY

Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21waf1/cip1 expression

(2010) Rintaro Noro et al.   CANCER SCIENCE

Survival comparison between glioblastoma multiforme and other incurable cancers

(2010) B. Tran et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

(2010) Jiahuai Tan et al.   Journal of Hematology & Oncology

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

(2009) A Rocca et al.   BRITISH JOURNAL OF CANCER

HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells

(2009) Xufeng Chen et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Successful Treatment of Anaplastic Thyroid Carcinoma with a Combination of Oral Valproic Acid, Chemotherapy, Radiation and Surgery

(2009) Hitoshi NOGUCHI et al.   ENDOCRINE JOURNAL

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

(2009) Evanthia Galanis et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

(2009) K. A. Jaeckle et al.   NEUROLOGY

Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma

(2008) Johannes E. A. Wolff et al.   JOURNAL OF NEURO-ONCOLOGY

A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid

(2008) Anita Ryningen et al.   LEUKEMIA RESEARCH

Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression

(2008) J.A. Benítez et al.   NEUROSCIENCE